115 results
Page 4 of 6
8-K
3qn2s0obd11ckjoz27
26 Jan 09
Departure of Directors or Principal Officers
12:00am
425
EX-99.1
m06me6v8f
26 Sep 08
Business combination disclosure
12:00am
425
qy1q9y1c 3b7
25 Sep 08
Business combination disclosure
12:00am
425
EX-99.1
5tl1folw1x 3r9k4
25 Sep 08
Business combination disclosure
12:00am
8-K
EX-99.1
fvyadmlmnq8 du51
25 Sep 08
Ligand to Acquire Pharmacopeia Webcast
12:00am
8-K
EX-99.2
qb6xqo3iturt6bx kf1v
24 Sep 08
1 Joseph A. Mollica, Ph.D., Chairman of the Board, Interim President & CEO, Pharmacopeia John L. Higgins, President & CEO
12:00am
425
EX-99.2
zcdwobai jzv5l6m2rrv
24 Sep 08
Business combination disclosure
12:00am
424B3
j5nzvarv24v9 e0v
4 May 07
Prospectus supplement
12:00am
8-K
EX-10
3of4qzt
4 May 07
Termination of a Material Definitive Agreement
12:00am
424B3
s7qa6zy4 8jk8pt
6 Feb 07
Prospectus supplement
12:00am
8-K
EX-99.1
981qluvi 9ola1l3
6 Feb 07
Ligand Announces Corporate Restructuring
12:00am
DEFM14A
q4tx3
24 Jan 07
Proxy related to merger
12:00am
424B3
1a7c5e2rdl
16 Jan 07
Prospectus supplement
12:00am
PRER14A
g7z1662au76
14 Dec 06
Preliminary revised proxy
12:00am
CORRESP
scm4a695
14 Dec 06
Correspondence with SEC
12:00am
PREM14A
ou4v5 24vi4eemz95n1
6 Nov 06
Preliminary proxy related to merger
12:00am
8-K
EX-99
lnp5iw1 5315
11 Sep 06
Regulation FD Disclosure
12:00am